WDFY1 and cancer: The third intron retention candidate, WD Repeat And FYVE Domain Containing 1 (WDFY1) enhances the production of inflammatory factors or IFN‐β by positive regulation of TLR3‐ and TLR4 signalling pathways and activation of NF‐κB,32 thereby promoting progression of melanoma,33, 34 and other serious types of cancer.35